Viewing Study NCT04562766


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-29 @ 4:35 PM
Study NCT ID: NCT04562766
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-10
First Post: 2020-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
Sponsor: Principia Biopharma, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module